Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer
Rengyun Liu, Justin A. Bishop, Guangwu Zhu, et al.
JAMA Oncology (2016) Vol. 3, Iss. 2, pp. 202-202
Closed Access | Times Cited: 244

Showing 1-25 of 244 citing articles:

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
David S. Ettinger, Douglas E. Wood, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network (2016) Vol. 14, Iss. 3, pp. 255-264
Open Access | Times Cited: 389
Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology
David L. Steward, Sally E. Carty, Rebecca S. Sippel, et al.
JAMA Oncology (2018) Vol. 5, Iss. 2, pp. 204-204
Open Access | Times Cited: 383
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018
Robert I. Haddad, Christian Nasr, Lindsay A. Bischoff, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 12, pp. 1429-1440
Open Access | Times Cited: 314
2019 European Thyroid Association Guidelines for the Treatment and Follow-Up of Advanced Radioiodine-Refractory Thyroid Cancer
Laura Fugazzola, Rossella Elisei, Dagmar Führer, et al.
European Thyroid Journal (2019) Vol. 8, Iss. 5, pp. 227-245
Open Access | Times Cited: 240
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Ricardo Leão, Joana Apolónio, Dong‐Hyun Lee, et al.
Journal of Biomedical Science (2018) Vol. 25, Iss. 1
Open Access | Times Cited: 223
TERT—Regulation and Roles in Cancer Formation
Marta Dratwa, Barbara Wysoczańska, Piotr Łacina, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 210
TERT promoter mutations in telomere biology
Barbara Heidenreich, Rajiv Kumar
Mutation Research/Reviews in Mutation Research (2016) Vol. 771, pp. 15-31
Closed Access | Times Cited: 185
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
Rengyun Liu, Tao Zhang, Guangwu Zhu, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 163
Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma
Weilin Pu, Xiao Shi, Pengcheng Yu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 141
Genomic alterations in thyroid cancer: biological and clinical insights
Iñigo Landa, Maria E. Cabanillas
Nature Reviews Endocrinology (2023) Vol. 20, Iss. 2, pp. 93-110
Closed Access | Times Cited: 43
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma
Joanna J. Phillips, Henry Gong, Katharine Chen, et al.
Brain Pathology (2018) Vol. 29, Iss. 1, pp. 85-96
Open Access | Times Cited: 119
Genetic landscape of papillary thyroid carcinoma in the Chinese population
Jialong Liang, Wanshi Cai, Dongdong Feng, et al.
The Journal of Pathology (2017) Vol. 244, Iss. 2, pp. 215-226
Closed Access | Times Cited: 118
Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis
Huy Gia Vuong, Ahmed Altibi, Uyen Duong, et al.
Clinical Endocrinology (2017) Vol. 87, Iss. 5, pp. 411-417
Open Access | Times Cited: 116
Patient Age–Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer
Xiaopei Shen, Guangwu Zhu, Rengyun Liu, et al.
Journal of Clinical Oncology (2017) Vol. 36, Iss. 5, pp. 438-445
Open Access | Times Cited: 107
The Genetic Duet of BRAF V600E and TERT Promoter Mutations Robustly Predicts Loss of Radioiodine Avidity in Recurrent Papillary Thyroid Cancer
Jiajun Liu, Rengyun Liu, Xiaopei Shen, et al.
Journal of Nuclear Medicine (2019) Vol. 61, Iss. 2, pp. 177-182
Open Access | Times Cited: 104
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Jie-Rui Liu, Yanqing Liu, Yansong Lin, et al.
Endocrinology and Metabolism (2019) Vol. 34, Iss. 3, pp. 215-215
Open Access | Times Cited: 101
Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
Ji Min Oh, Byeong‐Cheol Ahn
Theranostics (2021) Vol. 11, Iss. 13, pp. 6251-6277
Open Access | Times Cited: 90
Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation
Naoki Oishi, Tetsuo Kondo, Aya Ebina, et al.
Modern Pathology (2017) Vol. 30, Iss. 11, pp. 1527-1537
Open Access | Times Cited: 89
MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN
Julia Ramírez-Moya, León Wert-Lamas, Pilar Santisteban
Oncogene (2018) Vol. 37, Iss. 25, pp. 3369-3383
Closed Access | Times Cited: 85
Papillary Thyroid Cancer Prognosis: An Evolving Field
Salvatore Ulisse, Enke Baldini, Augusto Lauro, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5567-5567
Open Access | Times Cited: 84
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
Jinwei Hu, Isabella J. Yuan, Saied Mirshahidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1950-1950
Open Access | Times Cited: 69
Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial
Vatche Tchekmedyian, Lara Dunn, Eric J. Sherman, et al.
Thyroid (2022) Vol. 32, Iss. 3, pp. 273-282
Open Access | Times Cited: 39
Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification
Tomohiro Chiba
Biomedicines (2024) Vol. 12, Iss. 4, pp. 712-712
Open Access | Times Cited: 9
A computational approach to assessing the prognostic implications of BRAF and RAS mutations in patients with papillary thyroid carcinoma
Tahereh Haghzad, Babak Khorsand, S. Adeleh Razavi, et al.
Endocrine (2024)
Closed Access | Times Cited: 9
TERT biology and function in cancer: beyond immortalisation
Ana Pestana, João Vinagre, Manuel Sobrinho‐Simões, et al.
Journal of Molecular Endocrinology (2017) Vol. 58, Iss. 2, pp. R129-R146
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top